Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337231 | 12633723 | 1 | I | 20160402 | 20160727 | 20160809 | 20160809 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062606 | BRISTOL MYERS SQUIBB | 81.82 | YR | M | Y | 0.00000 | 20160809 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337231 | 12633723 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 1 DF, QD | Y | 9218 | 1 | DF | TABLET | QD | |||||
| 126337231 | 12633723 | 2 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 4 MG, UNK | Y | 9218 | 4 | MG | TABLET | QD | |||||
| 126337231 | 12633723 | 3 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 1.25 MG, QD | U | 0 | 1.25 | MG | QD | ||||||
| 126337231 | 12633723 | 4 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
| 126337231 | 12633723 | 5 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | QD | ||||||
| 126337231 | 12633723 | 6 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 126337231 | 12633723 | 7 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | 50 ?G, QD | U | 0 | 50 | UG | QD | ||||||
| 126337231 | 12633723 | 8 | C | NOCTAMIDE | LORMETAZEPAM | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | QD | ||||||
| 126337231 | 12633723 | 9 | C | SERESTA | OXAZEPAM | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126337231 | 12633723 | 1 | Atrial fibrillation |
| 126337231 | 12633723 | 3 | Product used for unknown indication |
| 126337231 | 12633723 | 4 | Product used for unknown indication |
| 126337231 | 12633723 | 5 | Product used for unknown indication |
| 126337231 | 12633723 | 6 | Product used for unknown indication |
| 126337231 | 12633723 | 7 | Product used for unknown indication |
| 126337231 | 12633723 | 8 | Product used for unknown indication |
| 126337231 | 12633723 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126337231 | 12633723 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126337231 | 12633723 | Acute kidney injury | |
| 126337231 | 12633723 | International normalised ratio increased | |
| 126337231 | 12633723 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126337231 | 12633723 | 1 | 20160327 | 20160329 | 0 | |
| 126337231 | 12633723 | 2 | 20160330 | 20160331 | 0 |